Astrazeneca Pharma India Ltd
Astrazeneca Pharma India Ltd Company History
Astrazeneca Pharma India is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. It has a workforce of over 1400 employees across the country that is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory.
2002
Ties up with Avestha for research on discovering drug for tuberculosis.
Makes an open offer to acquire the balance 21,75,050 equity shares of Astrazeneca pharma India Ltd representing 43% stake.
Government okays FDI proposal for the company and Tata Homefinance from 56.69% to 100% accounting for Rs.82 crs.
Astra Pharma acquires 32800 equity shares of Astrazeneca.
2002
2003
Astra Pharma and Astrazeneca jointly acquires less than 4% additional equity Astrazeneca Pharma India Ltd.
Sri Tom McKillop, inaugurates R & D centre in Bangalore at a cost of $40 million.
Approaches Union government for Exclusive Marketing Rights for new two generation anti-cancer drugs.
Astrazeneca Pharma India Limited Board accepts resignation of Mr. J G Zetterberg, Director, effective from the close of May 05, 2004.
2003
2006
AstraZeneca acquires Eli Lilly's Vancocin brand
Company has splits its Face value of Shares from Rs 10 to Rs 2
2006
2007
AstraZeneca Pharma India Ltd has appointed Mr. Ruud Dobber as Director of the Company.
2007
2010
AstraZeneca Pharma and biopharmaceutical company Bristol-Myers Squibb launched their 9-month-old diabetes drug Onglyza in India - the biggest market for the drug.Onglyza, or saxagliptin, is used to treat type 2 diabetes in adults.
AstraZeneca Pharma India Ltd has appointed Ms. Anita Zutshi as the Chief Financial Officer of the Company.
2010
2011
AstraZeneca Halts Late-Stage Trial of Prostate Cancer Medicine Zibotentan
Appointment of Mr. Himanshu Agarwal as the CFO of the Company
2011
2012
AstraZeneca Excellence in Chemistry Awards 2011
AstraZeneca and Cellworks Collaborate to find new Treatment for Tuberculosis
AstraZeneca launches its patented life-saving heart drug BRILINTA® (Ticagrelor) in India
2012
2013
AstraZeneca to acquire Bristol-Myers Squibb share of global diabetes alliance assets
AstraZeneca enters co-promotion agreement with Janssen in Japan for innovative prostate cancer treatment.
2013
2014
AstraZeneca and Bristol-Myers Squibb Company today announced the US Food and Drug Administration (FDA) approved FARXIGAÂ (dapagliflozin).
AstraZeneca and MRC enter strategic collaboration to create new centre for early drug discovery in Cambridge, UK .
AstraZeneca and Roche announce partnership to develop companion diagnostic test for AZD9291
The Registered Office of the Company has been shifted from 'Avishkar', Off Bellary Road, Hebbal, Bangalore - 560 024 to Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, Bangalore - 560 045.
2014
2015
AstraZeneca Pharma India Limited and Dr ReddyÂs Laboratories Limited enter distribution agreement for saxagliptin and its fixed dose combination with metformin, in Type 2 Diabetes
AstraZeneca Pharma launches type-2 diabetes treatment drug
BRILIQUE (ticagrelor) receives positive European Union CHMP opinion for extended treatment of patients with a history of heart attack
AstraZeneca completes acquisition of ZS Pharma
AstraZeneca opens new manufacturing facility to support continued growth in Russia
2015
2017
AstraZeneca Pharma receives import permission for inhaler powder.
AstraZeneca Pharma receives approval for Osimertinib Tablet.
2017
2018
AZPIL receives permission for Durvalumab from Drug Controller General of India.
2018
2021
AstraZenecaÂs Partners With DocOn to Digitise Healthcare Clinics Across India.
AstraZeneca in collaboration with Rajiv Gandhi Cancer Institute announces the launch of Project Chariot to help diagnose and treat patients with Chronic Lymphocytic Leukemia (CLL).
AstraZeneca launches Clinical Data and Insights division in India.
2021
2022
AstraZeneca Pharma gets CDSCO nod for Dapagliflozin tablets.
2022
2023
AstraZeneca Inaugurates "Centre of Excellence" at Manipal Hospital Goa for Severe Asthma Patients.
AstraZeneca India partners with Roche Diagnostics India to improve diagnostic testing for breast cancer patients.
Govt. of Karnataka signs MoU with AstraZeneca India to accelerate Lung Cancer testing.
2023
